Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Synovioma

gemcitabine has been researched along with Synovioma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Barwad, A; Bhatnagar, S; Bhoriwal, S; Dhamija, E; Kumar, A; Mridha, AR; Rastogi, S; Shamim, SA; Tansir, G1
Al-Muderis, O; Benson, C; Chauhan, D; Davis, EJ; Fisher, C; Jones, RL; Judson, I; Keedy, VL; Messiou, C; Miah, A; Pender, A; Thway, K; van der Graaf, W; Zaidi, S1
Madlon-Kay, R; Patel, M; Raza, A; Skubitz, K; Vakil, K; Zakharova, M1
Grignani, G; Martín-Broto, J; Reichardt, P; Schuler, M1
Cruz, CO; de Torres, C; Mora, J; Parareda, A1
Abe, K; Furuhashi, S; Maebayashi, T; Sakaguchi, M; Shizukuishi, T; Sugitani, M; Takahashi, M; Tanaka, Y; Uematsu, A1
Chen, Y; Shi, Y; Wang, C; Yang, Y1
Bean, A; Eckardt, MA; Federman, N; Selch, MT1

Trials

2 trial(s) available for gemcitabine and Synovioma

ArticleYear
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma.
    BMC cancer, 2023, Jul-08, Volume: 23, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Quality of Life; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Treatment Outcome

2023
Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Deoxycytidine; Disease Progression; Docetaxel; Female; Gemcitabine; Humans; Male; Osteosarcoma; Outpatients; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Survival Analysis; Taxoids; Treatment Outcome

2009

Other Studies

6 other study(ies) available for gemcitabine and Synovioma

ArticleYear
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.
    Medical oncology (Northwood, London, England), 2018, Aug-20, Volume: 35, Issue:10

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Palliative Care; Retrospective Studies; Sarcoma, Synovial; Treatment Outcome; Young Adult

2018
An absolute obstacle: cardiac metastasis of synovial sarcoma.
    The American journal of medicine, 2014, Volume: 127, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Disease Progression; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fatal Outcome; Gemcitabine; Heart Atria; Heart Neoplasms; Humans; Ifosfamide; Male; Polyethylene Glycols; Sarcoma, Synovial; Shoulder; Treatment Failure; Treatment Refusal; Vascular Neoplasms; Vena Cava, Superior

2014
Trabectedin clinical cases: use according to indication in diverse clinical scenarios.
    Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl

    Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Contraindications; Dacarbazine; Deoxycytidine; Dioxoles; Female; Femoral Neoplasms; Gemcitabine; Humans; Hysterectomy; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Thigh; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome; Uterine Neoplasms

2015
Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Humans; Hyperthermia, Induced; Ifosfamide; Neoplasm Proteins; Oncogene Proteins, Fusion; Pleural Neoplasms; Radiotherapy, Adjuvant; Sarcoma, Synovial; Tomography, X-Ray Computed; Vincristine

2010
Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients.
    Journal of surgical oncology, 2012, Aug-01, Volume: 106, Issue:2

    Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Extremities; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Remission Induction; Sarcoma, Synovial; Soft Tissue Neoplasms; Taxoids

2012
A child with gemcitabine-induced severe radiation recall myositis resulting in a compartment syndrome.
    Journal of pediatric hematology/oncology, 2013, Volume: 35, Issue:2

    Topics: Adolescent; Antimetabolites, Antineoplastic; Combined Modality Therapy; Compartment Syndromes; Deoxycytidine; Female; Gemcitabine; Humans; Radiodermatitis; Sarcoma, Synovial

2013